POPULATION OF INTEREST

The population of interest are all trauma patients with penetrating injury or diagnosis of open wound (includes open fracture or joint).

INTENT (EXPECTED OUTCOMES)

1. All patients in the population of interest receive the preferred or alternate antibiotic, or reason for different choice is documented.
2. All patients in population of interest have antibiotic administered within 3 hours of injury.
3. All patients in population of interest have a duration of prophylactic antibiotic use less than 72 hours, or documentation of reason for extended use.
4. All patients in population of interest admitted to the ICU have daily antiseptic body cleaning (for example, Sage, Chlorhexadine).

PERFORMANCE/ADHERENCE MEASURES

1. Number and percentage of patients in the population of interest who receive the preferred or alternate antibiotic.
2. Number and percentage of patients in the population of interest who receive other antibiotics (or and reason for different choice of antibiotics is documented).
3. Number and percentage of patients in the population of interest who have an antibiotic administered within three hours of injury.
4. Number and percentage of patients in the population of interest who have a duration of prophylactic antibiotic use less than 72 hours or documentation of reason for extended use.
5. Number and percentage of patients in the population of interest admitted to the ICU that have antiseptic body cleaning daily.

DATA SOURCES

- Patient Record
- Department of Defense Trauma Registry (DoDTR)

SYSTEM REPORTING & FREQUENCY

The pervious sections constitute the minimum criteria for PI monitoring of this CPG. System reporting will be performed annually; additional PI monitoring and system reporting may be performed as needed.

The JTS Chief, JTS Program Manager, and the JTS PI Branch will perform the system review and data analysis.

RESPONSIBILITIES

It is the trauma team leader’s responsibility to ensure familiarity, appropriate compliance, and PI monitoring at the local level with this CPG.